Fundraising Fox
/Companies
Sign in

Latus

Philadelphia, US · Founded 2022 · 28 employees on LinkedIn · 10 known investors

Find your way into Latus

Sign up to see every warm intro you have to Latus

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Latus team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Latus develops gene therapy research and development capabilities leveraging cell and gene therapy expertise. The company operates from Philadelphia and Boston, serving the biotechnology and therapeutics industry.

AI & Machine LearningBiotechDeep TechHealthtech

Investors · 10

8VCreportedAustin · $500K – $50M

How we know: funding news · biospace.com · Not right? Tell us

BioAdvancereportedConshohocken · $500K – $1.5M

How we know: biospace.com · Not right? Tell us

DCVC (Data Collective)reportedPalo Alto · $5M – $25M

How we know: the VCSheet dataset · Not right? Tell us

DCVC BioreportedPalo Alto

How we know: biospace.com · Not right? Tell us

GaingelsreportedNew York · $200K – $500K

How we know: biospace.com · Not right? Tell us

Korea Development BankreportedSeoul

How we know: biospace.com · Not right? Tell us

Modi VenturesreportedHouston

How we know: biospace.com · Not right? Tell us

Also in the syndicate · 2

Benjamin Franklin Technology PartnersHelen’s Pink Sky Foundation

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Latus Bio Raises $43M in Series A Fundingfinsmes.com · May 2026Latus Bio Announces $97 Million Series A Financing to Expand the Reach of Gene Therapy to Larger Populations - BioSpacebiospace.com · May 2026

Frequently asked questions

What does Latus do?
Latus develops gene therapy research and development capabilities leveraging cell and gene therapy expertise. The company operates from Philadelphia and Boston, serving the biotechnology and therapeutics industry.
Who are Latus's investors?
Latus's investors include Hatch BioFund, 8VC, BioAdvance, DCVC (Data Collective), DCVC Bio, Gaingels, Korea Development Bank, Modi Ventures.
Where is Latus headquartered?
Latus is headquartered in Philadelphia, US.